Transoral minimally invasive head and neck surgery has revolutionized the treatment of human papillomavirus (HPV)–positive oropharyngeal squamous cell carcinoma (OPC). 1 In 2009 and again in 2019, the ...

Mucoepidermoid carcinoma is a cancer of the salivary glands. Find out how common it is, symptoms, risk factors, treatment options and more.

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

Papillary renal cell carcinoma is a type of kidney cancer that starts in the kidneys' tubules. Read about the symptoms, diagnosis, treatment, and outlook.

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

Invasive Lobular Carcinoma is a unique breast cancer subtype with distinct features and challenges. Explore its diagnosis, treatment, and future strategies.

Urothelial carcinoma, or transitional cell carcinoma, is the most common bladder cancer and grows in the urothelial cells lining the urinary tract.

Penpulimab-kcqx, a humanized immunoglobulin G1 monoclonal antibody, blocks the interaction between the programmed death 1 receptor on T-cells and programmed death ligand 1 and 2 on tumor cells.

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. Multiple treatment modalities are available for the management of HCC, depending on its stage as ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...

A 59-year-old man with a history of metabolic dysfunction–associated steatotic liver disease had an enlarging liver mass. Biopsy showed hepatocellular carcinoma. Management decisions were made.